Complete Guide to CPT 99202–99215

Schedule Your Free Consultation

40% of E/M claims miscoded costing practices significant revenue

$58K average annual revenue lost per provider from E/M errors

2021 landmark E/M guideline overhaul changed everything for billing

9 active E/M office visit codes spanning new and established patients

INTRODUCTION

The E/M Coding Problem That Is Quietly Draining Endocrinology Revenue

Here is something that surprises a lot of endocrinology practices when they finally sit down for a billing audit: the codes generating the most revenue in their practice are also the codes they are most likely to be getting wrong.

Office visit evaluation and management codes CPT 99202 through 99215 drive the majority of outpatient billing revenue for endocrinologists. Every diabetes management follow-up, every thyroid consultation, every complex medication adjustment visit gets billed under this code set. And yet a significant percentage of endocrinology providers are either under-coding out of caution, over-coding without adequate documentation, or simply guessing at the right level because nobody ever sat down and explained the rules in plain language.

The 2021 AMA E/M guideline changes fundamentally restructured how these codes work. The old three-key-components system history, physical exam, medical decision making is gone for office-based visits. In its place is a cleaner, more provider-friendly framework built on MDM complexity or total encounter time. But nearly four years later, many endocrinology practices are still navigating that transition with incomplete information, outdated workflows, or coding staff who trained under the old system.

This guide is the resource we wish every endocrinology practice had access to before they started billing. We walk through every code in the 99202 to 99215 series, explain the MDM framework in plain terms, address the documentation questions that come up most in our billing audits, and give you the denial prevention and reimbursement optimization strategies that actually work for endocrinology-specific billing patterns.

💡  What You Will Get From This Guide

A complete, practical reference for E/M coding in endocrinology from understanding the difference between 99213 and 99214, to building MDM documentation habits that protect you in an audit, to identifying the revenue you may be leaving uncollected from under-coded visits. No filler, no generic advice just the billing intelligence that endocrinology practices actually need.

CODE OVERVIEW

CPT 99202–99215 at a Glance: New vs Established Patient Codes

The 99202 to 99215 series is divided into two distinct patient categories, and using the wrong category is one of the most common billing errors in outpatient endocrinology. The distinction matters both for compliance and for reimbursement, since the code levels within each category have meaningfully different documentation thresholds.

New vs Established Patient: The Rule That Matters

A new patient is defined as someone who has not received any professional services from the physician or another physician of the same specialty within the same group practice during the past three years. An established patient is anyone who does not meet that definition. When you are unsure, default to established patient coding it is the safer compliance choice and rarely costs you meaningful reimbursement at the higher levels.

Patient Type	CPT Code Range	Code Levels	Code 99211 Available?	Minimum Complexity
New Patient	99202 to 99205	4 active levels	No	Straightforward MDM or 15 to 29 min
Established Patient	99211 to 99215	5 active levels	Yes	Minimal (nurse visit) to high complexity

One important nuance: CPT 99201 was deleted in 2021. If your billing system still has 99201 active as a selectable code, that is an error that needs to be corrected immediately any claims submitted with 99201 after January 2021 are non-payable.

QUICK REFERENCE

CPT 99202–99215 Complete Reference Table

This table gives you the full picture for each code the patient type, the time threshold, the MDM level required, and the most common scenarios in endocrinology where each code applies. Use it as your primary reference when building or auditing your coding workflows.

⚠️  Medicare Rate Disclaimer

Rates shown above reflect approximate 2026 Medicare Physician Fee Schedule allowables and will vary by geographic location (locality adjustments apply). Commercial payer rates are negotiated separately and are typically higher than Medicare in most markets. Always verify current rates through your payer contracts and the CMS fee schedule lookup tool.

GUIDELINE CHANGES

The 2021 E/M Guideline Changes: What Actually Changed and Why It Matters

January 1, 2021 was the most significant date in outpatient E/M billing in more than two decades. The AMA overhauled the documentation guidelines for office-based E/M services in a way that was designed to reduce administrative burden on physicians and make code level selection more clinically meaningful. Four years later, the impact on endocrinology practices has been significant but only for those who actually updated their workflows.

What Was Eliminated in 2021

✔  The requirement to document a specific number of history elements (HPI, ROS, PFSH) to justify E/M level selection

✔  The organ systems examination requirement as a determinant of code level

✔  The three-key-components documentation framework that many providers had spent years memorizing

✔  CPT 99201, which was deleted entirely straightforward new patient visits now start at 99202

✔  Medical necessity documentation that mirrored the history/exam/MDM structure used by payers before 2021

What Replaced It

✔  A simplified two-pathway selection method: choose your E/M level based on total time OR based on MDM complexity whichever best reflects the encounter

✔  An updated MDM framework with three components: number and complexity of problems, amount and complexity of data reviewed, and risk of complications and morbidity

✔  Time-based coding now includes all provider time on the date of the encounter, not just face-to-face time including documentation time, care coordination, and test result review

✔  History and physical exam documentation is still recommended for clinical completeness but is no longer required to justify a specific code level

💡  The Practical Impact for Endocrinology

Most endocrinologists were significantly under-coding their complex diabetes management visits under the old three-key-components system because exam documentation requirements made higher-level coding feel risky. Under the 2021 guidelines, a well-documented diabetes management visit with medication adjustment and CGM data review typically supports 99214 or 99215 based on MDM alone — without needing to document a 12-organ-system review. Practices that have not recalibrated their coding to the 2021 framework are likely leaving substantial revenue on the table every single month.

MEDICAL DECISION MAKING

Medical Decision Making (MDM) Explained for Endocrinology Providers

MDM is the component of E/M coding that most directly reflects the clinical complexity of what a physician actually does during an encounter. Under the 2021 guidelines, MDM alone without any time documentation can justify the highest-level E/M codes. For endocrinologists managing complex patients, understanding MDM deeply is the single most valuable coding skill you can develop.

MDM is assessed across three elements. To reach a specific MDM level, you must meet or exceed the threshold in at least two of the three elements.

MDM Level	Problems (Element 1)	Data Reviewed (Element 2)	Risk (Element 3)	Supported Code
Straightforward	1 self-limited or minor problem	Minimal or none	Minimal risk	99202 / 99212
Low Complexity	2 or more self-limited; 1 stable chronic illness	Limited order or review of tests	Low risk; OTC drug management	99203 / 99213
Moderate Complexity	1 or more chronic illnesses with exacerbation; new undiagnosed problem	Moderate independent interpretation; external records review	Moderate risk; Rx drug management; procedure ordering	99204 / 99214
High Complexity	1 or more chronic illnesses with severe exacerbation; threat to life or bodily function	Extensive — independent interpretation; discussion with external provider	High risk; drug therapy with intensive monitoring; elective major surgery	99205 / 99215

How MDM Applies to Common Endocrinology Visits

One of the most common questions endocrinologists ask us is whether their typical diabetes management follow-up supports 99213 or 99214. The honest answer depends entirely on what is documented in the note not on what happened in the room.

TIME-BASED CODING

Time-Based E/M Coding: When to Use It and How to Document It Correctly

Time-based coding is the second pathway for selecting your E/M level, and for many endocrinology visits particularly complex diabetes management encounters involving extensive patient education, care coordination, and documentation time it is often the more appropriate choice.

Under the 2021 guidelines, total time on the date of the encounter counts, not just time spent face-to-face with the patient. This is a significant change that many practices have not fully incorporated into their workflow.

What Counts as Billable Time

✔  Reviewing test results, imaging reports, and external records before the patient arrives or after they leave

✔  Preparing and reviewing the patient's care management plan

✔  Documentation time the time spent completing the visit note, either during or after the encounter

✔  Care coordination with other providers, including referrals and communication with specialists

✔  Patient education and counseling when performed by the billing physician

✔  Ordering tests, medications, and procedures

What Does Not Count as Billable Time

✔  Time spent by clinical staff who are not the billing physician medical assistants, nurses, certified diabetes educators cannot contribute to physician time for E/M coding

✔  Time performing separately billable procedures on the same date if you perform a CGM interpretation and bill it separately, that time cannot also count toward E/M time

✔  Time spent on administrative tasks unrelated to the patient's care management

Total Encounter Time	New Patient Code	Established Patient Code
Less than 15 minutes	Not billable	99211 (clinical staff visit)
15–29 minutes	99202	Not applicable
10–19 minutes	Not applicable	99212
20–29 minutes	Not applicable	99213
30–44 minutes	99203	Not applicable
30–39 minutes	Not applicable	99214
40–54 minutes	Not applicable	99215
45–59 minutes	99204	Not applicable
55–74 minutes	Not applicable	99215 + prolonged service code if applicable
60–74 minutes	99205	Not applicable
75+ minutes	99205 + prolonged	99215 + prolonged service code

💡  Pro Tip: Document Time Explicitly in the Note

When billing based on time, your note must explicitly state the total time spent on the encounter date. A phrase like 'Total encounter time: 38 minutes, including pre-visit record review, the face-to-face visit, and post-visit documentation' is sufficient and it is the sentence that protects you in an audit. Vague time references or estimates without supporting context are a compliance liability.

DOCUMENTATION REQUIREMENTS

E/M Documentation Requirements: What Your Notes Actually Need to Include

This is the section that trips up the most endocrinology practices. The 2021 guidelines eliminated many of the rigid documentation requirements of the previous framework, but they did not eliminate the need for clinical documentation that supports the code level selected. A brief, vague note documenting a 99215 is an audit liability regardless of which coding pathway you used.

The Documentation Checklist for High-Quality E/M Notes

✔  Chief complaint or reason for the visit stated clearly at the top of the note

✔  Relevant history that supports the clinical complexity being documented not every system, but the ones relevant to today's decision-making

✔  Assessment that clearly identifies each active problem addressed during the encounter with specificity not just 'diabetes' but 'Type 2 diabetes with suboptimal glycemic control, A1C 9.1%'

✔  Plan that documents specific clinical decisions: what was changed, what was ordered, what was deferred and why, what patient education was provided

✔  For MDM-based coding: explicit documentation of the problems addressed, data reviewed and how you interpreted it, and the risk associated with your clinical decisions

✔  For time-based coding: a clear statement of total time with a brief description of what activities comprised that time

✔  Care coordination documentation when relevant — who you communicated with, what was discussed, and what was decided

⚠️  The Audit Trigger Most Endocrinologists Do Not Know About

Payers are increasingly using automated tools to flag E/M claims where the visit note appears to be copy-pasted from a previous encounter. If your diabetes follow-up notes look nearly identical visit to visit — same problem list, same plan language, same data reviewed — with only dates changed, you are creating an audit liability. Each note needs to reflect the specific clinical decisions made on that date, even if the overall treatment plan is stable.

MODIFIER USAGE

Modifier Usage for E/M Services in Endocrinology

Modifiers are the most nuanced part of E/M billing, and using them incorrectly is one of the fastest ways to generate a denial or an audit. Here are the modifiers that come up most frequently in endocrinology E/M billing and exactly when each applies.

Modifier	When It Applies	Common Endocrinology Use	Compliance Risk Without It
25	Significant, separately identifiable E/M on same day as a procedure	E/M visit on same day as CGM professional interpretation, thyroid biopsy, or RPM service	E/M will be bundled into the procedure and denied or non-reimbursed
57	E/M decision for major surgery	Rarely applicable in outpatient endocrinology	N/A for most outpatient scenarios
95	Synchronous telemedicine service	Telehealth endocrinology visits when payer requires it	Denial or place-of-service mismatch resulting in non-payment
GT	Interactive audio and video telemedicine (TRICARE and some commercial)	Telehealth visits for TRICARE patients and some commercial plans still requiring GT	Non-payment for covered telehealth visit
GQ	Asynchronous telemedicine	Store-and-forward consultations rare in endocrinology	Incorrect payment processing
33	Preventive service — no patient cost-sharing	Rare in endocrinology; applies when preventive diabetes counseling billed	Patient cost-sharing applied incorrectly
FQ	Direct supervision by supervising physician via real-time audio/video	Teaching practice scenarios with remote physician supervision	Compliance risk in teaching settings without correct modifier

💡  Modifier 25 Is the Most Important E/M Modifier for Endocrinologists

If you perform a CGM professional interpretation, a bone density study interpretation, or any separately billable procedure on the same day as an office visit, Modifier 25 must be appended to the E/M code. Without it, payers will bundle the E/M with the procedure and pay only the procedure you lose the entire E/M reimbursement. The modifier requires documentation showing that the E/M addressed a problem separate from what prompted the procedure, or at minimum addressed additional clinical issues during the same encounter.

TELEHEALTH E/M BILLING

Telehealth E/M Billing for Endocrinology: What the Rules Look Like in 2026

Telehealth billing for endocrinology has been in a state of almost constant policy change since 2020, and the situation in 2026 is still more complicated than most practices realize. The temporary flexibilities extended through the COVID-19 public health emergency have been expiring on a rolling basis, while some have been made permanent or extended through Congressional action.

What Is Currently Permanent for Medicare Telehealth E/M

✔  Audio and video telehealth visits (synchronous) at the same rates as in-person visits through at least December 31, 2026 under the Consolidated Appropriations Act

✔  Patients can receive telehealth at home — originating site restrictions removed for the extended period

✔  Mental health visits require an in-person visit within 6 months of initiating telehealth care not typically relevant for endocrinology but worth knowing for practices that also manage mental health comorbidities

✔  Standard E/M codes (99202 through 99215) are payable via telehealth with appropriate place-of-service coding

Place-of-Service Coding for Telehealth E/M

Telehealth Scenario	Place of Service Code	Modifier Required?	Reimbursement Impact
Patient at home, Medicare	10 (Patient's home)	No modifier needed for Medicare	Same rate as in-office visit
Patient at a telehealth originating site, Medicare	02 (Telehealth non-patient home)	No modifier needed for Medicare	Same rate as in-office visit
Commercial payer, payer-specific rules apply	Varies by payer check contract	Modifier 95 or GT depending on payer	Varies — confirm with payer contract
TRICARE	02 or per TRICARE guidelines	GT required	Payer-specific rate

⚠️  Telehealth Documentation Is the Same as In-Person Documentation

Many practices incorrectly assume that telehealth visits have less stringent documentation requirements because the encounter is virtual. They do not. The same MDM or time-based documentation standards apply to telehealth E/M codes as to in-person visits. The only difference is the place-of-service code and, in some cases, a modifier. Your notes need to reflect the same clinical complexity and decision-making that they would for an equivalent in-person encounter.

COMMON CODING MISTAKES

Common E/M Coding Mistakes in Endocrinology and How to Avoid Every One

❌  Under-Coding Errors (Revenue Lost) ❌  Coding 99213 for complex diabetes visits that clearly support 99214 based on MDM — the most common under-coding mistake in endocrinology ❌  Not using time-based coding for long, education-heavy diabetes visits that run 35 to 45 minutes including documentation ❌  Billing 99211 for visits where a physician is actually performing decision-making — 99211 is a clinical staff code ❌  Failing to capture prolonged services codes when encounters consistently exceed the maximum time threshold for 99215 ❌  Routinely selecting the same code for every visit type regardless of complexity — flat coding is a revenue and compliance problem simultaneously ❌  Not billing for CCM and RPM services alongside E/M codes when patients clearly qualify for both

❌  Over-Coding Risks (Compliance Exposure) ❌  Billing 99215 for routine diabetes follow-up visits where documentation only supports moderate complexity MDM ❌  Using time-based coding without documenting total time explicitly in the note — a note saying the visit lasted approximately 40 minutes is not sufficient ❌  Upcoding stable chronic disease visits by listing multiple diagnoses without documenting that each was actively managed during the encounter ❌  Copy-pasting previous visit notes to inflate apparent complexity without updating them to reflect current clinical decisions ❌  Billing a new patient code for a patient who was seen by a partner in the same group practice within the past three years ❌  Selecting a higher MDM level based on the complexity of the patient rather than the complexity of the decision-making performed today

DENIAL PREVENTION

E/M Denial Prevention: The Most Frequent Endocrinology E/M Denials and Their Fixes

E/M denials in endocrinology follow consistent patterns. Once you know the patterns, most of them are preventable with the right coding and documentation workflows in place.

AUDIT RISK & COMPLIANCE

Audit Risk and Compliance: Protecting Your Endocrinology Practice

E/M audits in endocrinology are not hypothetical they happen, and they are expensive. The Office of Inspector General has consistently included E/M billing accuracy in its Work Plan, and Medicare Administrative Contractors conduct regular prepayment and post-payment reviews of E/M claims across specialties. Commercial payers have their own audit programs, and they have become more sophisticated in identifying statistical outliers.

The Endocrinology-Specific Audit Triggers You Need to Know

⚠️  Billing a disproportionately high percentage of 99214 or 99215 codes relative to peers in your specialty and geographic market outlier billing patterns are flagged automatically by payer analytics systems

⚠️  Consistently billing the same high-level code for every visit, regardless of visit type known as 'upcoding by habit' and a reliable audit trigger

⚠️  High frequency of Modifier 25 usage without corresponding procedure claims if you are consistently billing Modifier 25 without a paired procedure, payers will investigate

⚠️  Visit notes that appear cloned or nearly identical across multiple encounters automated similarity detection is standard in modern payer audit tools

⚠️  Time-based billing without explicit time documentation selected for audit because it is easy to identify and verify

🛡️  Build Your Compliance Defense Before You Need It

The best time to conduct an internal E/M coding audit is before an external audit happens. A structured review of 20 to 30 randomly selected E/M claims per quarter checking code selection against documentation will identify your risk areas and give you the opportunity to correct them proactively. Document your audit process and your corrective actions. That documentation is your best defense if a payer does initiate a formal review.

REIMBURSEMENT OPTIMIZATION

Reimbursement Optimization Strategies for Endocrinology E/M Billing

Optimizing E/M reimbursement in endocrinology is not about finding ways to upcode. It is about ensuring that the complexity of what you actually do is accurately reflected in the code you select and in the documentation that supports it. Most endocrinology practices that optimize their E/M billing find that they were significantly under-coding rather than over-coding.

The Revenue Impact of Getting E/M Coding Right

The difference between 99213 and 99214 is approximately $42 in Medicare reimbursement. That sounds modest in isolation. But for an endocrinology practice seeing 20 established patients per day, five days per week, with 250 working days per year if just 30 percent of those visits are under-coded by one level, that represents $63,000 in uncollected annual revenue from Medicare alone. Commercial payer rates amplify that number significantly.

We regularly see endocrinology practices recover $40,000 to $90,000 annually in revenue through proper E/M coding calibration alone without changing a single clinical workflow. The visits were already happening. The complexity was already there. It simply was not being captured in the code or the documentation.

OUTSOURCING BENEFITS

Why Endocrinology Practices Outsource E/M Billing to Specialty Experts

E/M coding for endocrinology requires a level of specialty knowledge that generalist billing staff rarely possess. The nuances of MDM documentation for complex diabetes management, the specific CGM and RPM coding rules that interact with E/M codes, the telehealth place-of-service requirements these are not skills that develop without dedicated experience in the specialty.

✅  What In-House Billing Teams Typically Struggle With ⚠️  Keeping up with annual E/M guideline updates and CMS transmittals that change coding rules mid-year ⚠️  Specialty-specific MDM documentation coaching for physicians who trained under the old three-key-components system ⚠️  Identifying under-coding patterns from within — in-house teams rarely have the benchmark data to know what normal looks like for endocrinology coding ⚠️  Managing the prior authorization workflows for CGM and insulin pump services that interact with E/M billing timelines ⚠️  Denial appeals with clinical rationale for medical necessity — requires both coding and clinical knowledge

✅  What MedCloudMD Brings to Endocrinology E/M Billing ✔  CPC-certified coders with active endocrinology billing experience who understand the clinical context behind each code ✔  Quarterly E/M coding calibration audits with benchmarking against specialty norms and identification of revenue recovery opportunities ✔  Physician-level documentation feedback that improves MDM capture without increasing documentation burden ✔  Integrated E/M and ancillary service billing — CCM, RPM, CGM interpretation all coordinated with E/M coding ✔  Real-time reporting dashboard showing your E/M code distribution, denial rates, and collection performance by code level

📋  Schedule Your Free E/M Coding Audit

Find out exactly which code levels your documentation supports — and where you may be leaving revenue uncollected. No commitment required.

🌐  medcloudmd.com/specialties/endocrinology-billing-services

FREQUENTLY ASKED QUESTIONS

E/M Coding FAQ — Answered Directly for Endocrinology Providers

Q1:  What is the difference between CPT 99213 and 99214 for endocrinology visits?

CPT 99213 requires low complexity MDM or 20 to 29 minutes of total encounter time, while 99214 requires moderate complexity MDM or 30 to 39 minutes. In endocrinology, the distinction typically comes down to prescription drug management. If a physician is adjusting a medication changing a dose, adding a new drug, or making a clinical decision about insulin or a diabetes medication that meets the moderate risk threshold that supports 99214. A straightforward refill of stable medication with no changes typically supports 99213. The specific clinical decisions made during the encounter, not the diagnosis itself, determine the correct level.

Q2:  Can I bill both a 99214 and a CGM interpretation code on the same day?

Yes, but Modifier 25 must be appended to the E/M code (99214-25) to indicate that it was a significant, separately identifiable service from the CGM interpretation. Your documentation must reflect that the E/M visit addressed clinical issues beyond or separate from the CGM data review, or that the E/M involved additional medical decision-making not captured in the interpretation. Without Modifier 25, payers will bundle the E/M into the procedure and pay only the procedure code.

Q3:  How do I document time correctly for time-based E/M coding?

Your note must include an explicit statement of total time spent on the encounter date. Include a description of what comprised that time — for example: 'Total encounter time today: 42 minutes, including pre-visit review of CGM data and recent labs, 28-minute face-to-face evaluation and education session, and post-visit documentation and care plan update.' The statement does not need to be elaborate, but it must be specific enough that an auditor can understand what activities comprised the total time documented.

Q4:  What ICD-10 codes should I use to support high-complexity MDM in diabetes billing?

Specificity is critical. E11.9 (Type 2 diabetes without complications) is not appropriate when your patient has documented complications or suboptimal control. Use E11.65 for uncontrolled Type 2 diabetes, E11.40 through E11.49 for diabetic neuropathy, E11.311 through E11.359 for diabetic retinopathy, and E11.65 combined with N18 codes for diabetic kidney disease. Each documented complication adds to the problem complexity element of MDM and helps justify higher-level coding when the clinical situation genuinely warrants it.

Q5:  Can a nurse practitioner or PA bill 99215 in my endocrinology practice?

Yes, under incident-to billing or when billing under their own NPI, with important distinctions. Under incident-to billing (physician NPI on the claim), the mid-level provider must see an established patient for a condition already initiated by the supervising physician, the physician must be physically present in the office suite during the visit, and the service must represent continuation of a treatment plan the physician established. The E/M level is determined by the documentation and complexity, not by who performs the service. Direct billing under the NPI of the NP or PA typically reimbursed at 85 percent of the physician rate under Medicare.

Q6:  What is the most common reason endocrinology E/M claims get denied by Medicare?

The most frequent Medicare denial for endocrinology E/M claims is lack of medical necessity the documentation in the note does not support the complexity level billed. This most often occurs when a provider selects a code level based on the clinical complexity of the patient rather than the clinical complexity of the decisions made during that specific encounter. A patient who is complex does not automatically generate a high-level E/M claim the note needs to document what was actually done, reviewed, decided, and why, on that date.

Q7:  Should I use MDM or time as my E/M coding basis for endocrinology visits?

Use whichever pathway more accurately reflects the encounter and you only need to meet the threshold for one pathway per visit. For most endocrinology visits, MDM is the stronger basis because it directly reflects clinical decision-making complexity. Time-based coding is most valuable for visits that are heavy on education, care coordination, or documentation diabetes self-management education visits, care management for patients with multiple comorbidities, and coordination-intensive insulin initiation encounters are good examples. You do not need to document both pathways choose the one that better represents the encounter and document it thoroughly.

Q8:  How many E/M visits can I bill per day per patient under Medicare?

Generally, Medicare allows one E/M service per patient per day from the same provider or group practice. Exceptions exist for specific circumstances such as a patient seen in the emergency department and then admitted, or when services occur at separate facilities. In outpatient endocrinology, if a patient is seen twice in one day for example for an initial consultation and then for a follow-up after test results return documentation must clearly justify why a second separate E/M was medically necessary and cannot be considered part of the same encounter.

NEXT STEP

Stop Under-Coding Your Endocrinology Visits — Start Collecting What You Earn

Every endocrinology visit you have already completed has a correct E/M code. The question is whether the code you billed reflects what actually happened in that room the clinical decisions you made, the data you reviewed, the time you invested, the complexity you managed.

For the majority of endocrinology practices we work with, the gap between what they bill and what their documentation actually supports runs into the tens of thousands of dollars per year. That is not revenue from billing more. That is revenue from billing correctly.

MedCloudMD works with endocrinology practices to build E/M coding workflows that are accurate, defensible, and optimized and we start every new relationship with a free, no-obligation billing performance audit so you know exactly where you stand before making any decisions.

Free E/M coding audit for endocrinology practices

48hrs Typical turnaround for audit findings and revenue assessment

HIPAA Fully compliant data handling and workflow management

$0 Commitment or obligation required to get started